Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19
Thursday, June 11, 2026Organon NYSE OGN today announced the US Food and Drug Administration FDA approval of the supplemental Biologics License Application sBLA for TOFIDENCE tocilizumabbavi injection for intravenous use a
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
Thursday, June 11, 2026GENESIS Pharma a leading regional biopharma company focused on the commercialization of innovative medicines in Europe today announced the expansion of its longstanding commercial partnership
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
Thursday, June 11, 2026MindWalk Holdings Corp MindWalk NASDAQ HYFT a bionative AI company today launched ReefIQ a HYFTpowered biological context layer for AI drug discovery and biologics development that sits between client discovery data
USP and BPOM Advance Global Laboratory Quality Standards Through Strategic Training Initiative
Wednesday, June 10, 2026In a major step forward for international regulatory alignment the United States Pharmacopeia USP partnered with the Indonesian Food and Drug Authority BPOM to conduct an intensive Advanced Laboratory
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
Wednesday, June 10, 2026SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure today announced that after entering into a license agreement with the US Centers for Disease
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
Wednesday, June 10, 2026XtalPi HK a leading platform in artificial intelligence AI and roboticsdriven drug discovery today announced a strategic partnership with a prominent international biopharmaceutical company
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
Wednesday, June 10, 2026Harbour BioMed the Company HKEX a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology oncology and other disease areas
Completion of Phase 1 Integration Aligns and Strengthens Gaelic and Athlone Labs
Tuesday, June 09, 2026The first steps in the integration of Irelands sole GMPapproved manufacturers of BetaLactam antibiotics which merged in December through a horizontal acquisition have met corporate objectives for synergy
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
Tuesday, June 09, 2026Johnson Johnson NYSE JNJ today announced it has entered into a definitive agreement to acquire Firefly Bio Inc a biotechnology company advancing its proprietary Firelink degrader antibody conjugate DAC platform
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
Tuesday, June 09, 2026Zai Lab Limited NASDAQ ZLAB HKEX today announced that Chinas National Medical Products Administration NMPA has approved the Biologics License Application BLA for TIVDAK tisotumab vedotin
